PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,767 | -42.0% | 7,098 | -24.2% | 0.00% | – |
| Q2 2023 | $375,416 | -51.5% | 9,369 | -50.6% | 0.00% | -100.0% |
| Q1 2023 | $774,125 | +32.6% | 18,969 | +25.5% | 0.00% | 0.0% |
| Q4 2022 | $583,627 | -53.0% | 15,116 | -35.3% | 0.00% | 0.0% |
| Q3 2022 | $1,243,000 | -7.0% | 23,354 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $1,337,000 | -11.8% | 22,929 | +15.4% | 0.00% | 0.0% |
| Q1 2022 | $1,516,000 | -6.0% | 19,870 | -25.9% | 0.00% | 0.0% |
| Q4 2021 | $1,613,000 | +16.2% | 26,804 | +8.2% | 0.00% | 0.0% |
| Q3 2021 | $1,388,000 | +2.4% | 24,777 | +10.9% | 0.00% | 0.0% |
| Q2 2021 | $1,355,000 | -1.8% | 22,337 | +13.5% | 0.00% | 0.0% |
| Q1 2021 | $1,380,000 | +45.1% | 19,682 | +23.6% | 0.00% | 0.0% |
| Q4 2020 | $951,000 | -7.4% | 15,923 | -6.8% | 0.00% | 0.0% |
| Q3 2020 | $1,027,000 | +32.2% | 17,090 | +15.4% | 0.00% | 0.0% |
| Q2 2020 | $777,000 | +48.0% | 14,808 | -5.3% | 0.00% | 0.0% |
| Q1 2020 | $525,000 | 0.0% | 15,639 | +34.8% | 0.00% | 0.0% |
| Q4 2019 | $525,000 | -69.4% | 11,600 | -74.3% | 0.00% | -50.0% |
| Q3 2019 | $1,718,000 | -27.2% | 45,116 | -16.9% | 0.00% | 0.0% |
| Q2 2019 | $2,360,000 | +116.1% | 54,292 | +89.2% | 0.00% | +100.0% |
| Q1 2019 | $1,092,000 | -35.6% | 28,701 | -27.2% | 0.00% | -50.0% |
| Q4 2018 | $1,695,000 | +5550.0% | 39,407 | +6057.3% | 0.00% | – |
| Q3 2018 | $30,000 | +3.4% | 640 | -26.2% | 0.00% | – |
| Q2 2018 | $29,000 | -82.8% | 867 | -84.1% | 0.00% | – |
| Q1 2018 | $169,000 | -52.7% | 5,443 | -30.4% | 0.00% | – |
| Q4 2017 | $357,000 | +21.8% | 7,819 | +0.6% | 0.00% | – |
| Q3 2017 | $293,000 | -10.7% | 7,770 | +13.3% | 0.00% | – |
| Q2 2017 | $328,000 | -6.6% | 6,859 | -10.6% | 0.00% | – |
| Q1 2017 | $351,000 | +33.5% | 7,668 | -5.5% | 0.00% | – |
| Q4 2016 | $263,000 | +13.9% | 8,112 | +20.8% | 0.00% | – |
| Q3 2016 | $231,000 | -4.5% | 6,713 | -6.5% | 0.00% | – |
| Q2 2016 | $242,000 | -12.6% | 7,180 | +37.7% | 0.00% | – |
| Q1 2016 | $277,000 | +1.5% | 5,215 | +46.2% | 0.00% | – |
| Q4 2015 | $273,000 | +5.0% | 3,568 | -43.7% | 0.00% | – |
| Q3 2015 | $260,000 | -56.5% | 6,343 | -24.9% | 0.00% | -100.0% |
| Q2 2015 | $598,000 | +41.7% | 8,443 | +77.5% | 0.00% | – |
| Q1 2015 | $422,000 | +1105.7% | 4,756 | +1101.0% | 0.00% | – |
| Q4 2014 | $35,000 | -5.4% | 396 | +5.0% | 0.00% | – |
| Q3 2014 | $37,000 | +19.4% | 377 | +12.2% | 0.00% | – |
| Q2 2014 | $31,000 | +34.8% | 336 | 0.0% | 0.00% | – |
| Q1 2014 | $23,000 | -20.7% | 336 | -32.8% | 0.00% | – |
| Q4 2013 | $29,000 | -19.4% | 500 | -33.3% | 0.00% | – |
| Q3 2013 | $36,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |